FAQ

Erectile Dysfunction stem cell therapy — your questions answered (2026)

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

About stem cell therapy for Erectile Dysfunction

Erectile dysfunction (ED) can reflect vascular, neurological, hormonal, medicine-related, psychological or structural factors and may signal wider cardiovascular disease. Cell, platelet-derived and exosome products are marketed as regenerative procedures, but their compositions and evidence differ and a proposed angiogenic mechanism does not establish reliable erections or long-term safety.

The evidence for Erectile Dysfunction

Evidence for cell products remains investigational and should use the exact preparation, route, comparator and validated erectile-function and safety outcomes. The NIDDK ED treatment guide describes evaluation of underlying causes, lifestyle measures, counselling, authorised medicines, devices and surgery. Those options should be assessed before an unapproved injection.

Request a written, itemised quote for assessment, exact product, administration, imaging where justified, follow-up and management of infection, bleeding, fibrosis or other complications. Do not let privacy concerns or a package discount replace independent urological and cardiovascular assessment.

Does stem cell therapy for ED work?

Cell therapy for Erectile Dysfunction may be offered as an individualised programme, but regulatory status depends on the product, processing, indication and jurisdiction. It is currently investigational. Verify authorisation status, cell source, release testing and clinical evidence for the specific proposal.

Is it permanent?

Schedules vary by the exact product, protocol, route, monitoring needs and clinical context. Request the proposed schedule and its evidence before making travel arrangements.

One session or several?

Eligibility depends on the protocol's inclusion and exclusion criteria and an appropriately qualified clinician's assessment. An online checklist cannot determine candidacy or replace medical advice.

Cost in the EU?

The partner-published indicative range for an Erectile Dysfunction programme is €3,000–€8,000 for treatment. Request a current written quotation and compare product, dose, visits, inclusions and follow-up before using country ranges as a benchmark.

Sources & further reading

We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.

Before deciding, verify the exact product, legal route, evidence, risks, alternatives and total cost. An online checklist is educational only and cannot determine candidacy.

← Back to Erectile Dysfunction overview · Erectile Dysfunction cost →

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information